Health Care - Latest News and breaking headlines - Benzinga

Health Care

What's Going On With BioCardia Stock Tuesday?

What's Going On With BioCardia Stock Tuesday?

EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch

EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch

AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease

AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease

EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch

EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch

AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease

AstraZeneca Reports Significant Proteinuria Reduction With Ultomiris In Rare Kidney Disease

Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages

Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages

Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages

Eli Lilly Highlights Weight Loss Benefits For Women Across Menopausal Stages

Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

Why Is Tango Therapeutics Stock Soaring Monday?

Why Is Tango Therapeutics Stock Soaring Monday?

GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent

GSK Makes Its Biggest Bet In More Than A Decade, Paying $10.6 Billion For Cancer Drug Developer Nuvalent

Health Care Recent News

Oscar Health Stock Is Trending After Jumping 12% On Monday: What's Going On?

Oscar Health Stock Is Trending After Jumping 12% On Monday: What's Going On?

Oscar Health shares surged after the company reaffirmed its 2026 outlook and provided a business update.

Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes

Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes

DexCom CONNECT trial found G7 reduced A1C and improved glucose control in Type 2 diabetes patients not using insulin.

Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study

Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study

Pfizer reports Phase 2b obesity drug data showing 15.9% weight loss as FDA expands HYMPAVZI use for hemophilia patients.

Why Is Shattuck Labs Stock Trading Lower On Monday?

Why Is Shattuck Labs Stock Trading Lower On Monday?

Shattuck Labs' stock tumbles after Phase 1 SL-325 data release despite analyst upgrades, a Buy consensus rating, and progress in IBD treatment.

Lyell Immunopharma Issues Colorectal Cancer Drug Safety Update

Lyell Immunopharma Issues Colorectal Cancer Drug Safety Update

Lyell Immunopharma reports improved safety data for LYL273 in metastatic colorectal cancer and advances study to Phase 1/2 design.

Nurix Therapeutics Gains Ground As Roche Partnership Targets Growing B-Cell Blood Cancer Market

Nurix Therapeutics Gains Ground As Roche Partnership Targets Growing B-Cell Blood Cancer Market

Nurix Therapeutics and Roche sign a BTK degrader partnership worth up to $2.3 billion, supporting Phase 3 plans for bexobrutideg.

Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'

Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'

Novo Nordisk exploring additional uses for obesity drug semaglutide, including potential for longevity and aesthetics.

Eli Lilly Could Become The World's Top AI Firm? Jordi Visser Has Reasons To Believe Mounjaro Maker Could Become The Largest Company Globally

Eli Lilly Could Become The World's Top AI Firm? Jordi Visser Has Reasons To Believe Mounjaro Maker Could Become The Largest Company Globally

Investor Jordi Visser says Eli Lilly could become the world's largest company and AI leader within five years due to its AI advantage.

Trump Admin Raises Bar For Medicaid's 'Medically Frail' Exemption Ahead Of Work Rules

Trump Admin Raises Bar For Medicaid's 'Medically Frail' Exemption Ahead Of Work Rules

Trump administration tightens Medicaid medical frailty exemption as states prepare for 2027 work requirements.

Reading, Math Proficiency Fell In 47 States As Child Wellbeing Slid Post-COVID, New Kids Count Report

Reading, Math Proficiency Fell In 47 States As Child Wellbeing Slid Post-COVID, New Kids Count Report

Children's wellbeing declined in 29 states since 2019 as education and health outcomes worsened, Kids Count report finds.

A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court

A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court

Abbott must face a class-action lawsuit over claims its PediaSure drinks are clinically proven to help kids grow taller, a judge rules.

Why Is BioCardia Stock Gaining Friday?

Why Is BioCardia Stock Gaining Friday?

BioCardia stock breaks above its 200-day moving average on huge FDA news. Can BCDA clear the $1.50 resistance? Get the technical outlook.

UnitedHealth Positioned As AI Leader: Analyst

UnitedHealth Positioned As AI Leader: Analyst

Morgan Stanley names UnitedHealth its top managed care pick, citing AI-driven growth, efficiency gains and improving operations.